InterVenn Biosciences⁠ Raised $34,000,000⁠ in Series B⁠ Funding

RAISE⁠
IMAGE: David Michael, Aldo Carrascoso, & Jenny Rooke⁠
DATE: 11/16/2020⁠
COMPANY: InterVenn Biosciences⁠
INVESTORS: Anzu Partners, Genoa Ventures, Amplify Partners, True Ventures, Xeraya Capital, & Ojjeh Family⁠
ROUND: Series B⁠
AMOUNT: $34,000,000⁠
NOTE: InterVenn is a biotech company that combines epiproteomics, instrumentation, and deep learning to augment cancer diagnosis. Founded in 2017, The company has raised $77.1M to date.⁠
HQ: #RedwoodCity #California #UnitedStates

#InterVennBiosciences
#AnzuPartners
#GenoaVentures
#AmplifyPartners
#TrueVentures
#XerayaCapital
#OjjehFamily
#AldoCarrascoso
#DavidMichael
#JennyRooke
#DavidBeyer
#TradedVC